Loading data for TMCI — first visit, this takes a few seconds.
Treace Medical Concepts, Inc. (TMCI)
: TMCI
· Real-Time Price · USD
7.08
n/a (n/a)
At close: Invalid Date
4.65
+0.00%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
Treace Medical Concepts, Inc. (TMCI) Stock Price, Analysis & Data
No data available
| Bid | n/a |
| Market Cap | n/a |
| Revenue (ttm) | 205M |
| Net Income (ttm) | -59.5M |
| 1.40 | |
| n/a | |
| n/a | |
| -5.47 | |
| P/B (ttm) | 4.46 |
| P/S (ttm) | 1.47 |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | NaN |
| Avg. Volume (20D) | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a - n/a |
| 52-Week Range | n/a - n/a |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About TMCI
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers...
Industry Medical Devices
Sector Healthcare
IPO Date Apr 23, 2021
Employees 450
Stock Exchange NasdaqGS
Ticker Symbol TMCI
Website https://www.treace.com
Financial Performance
In 2025, Treace Medical Concepts's revenue was 212.69M, an increase of 1.59% compared to the previous year's 209.36M. Earnings were -59M, an increase of 5.85%.
Financial StatementsEarnings Surprise
Treace Medical Concepts has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.